Kintz Samuel
PRESIDENT AND CEO
Kintz Samuel has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2025.
On the most recent filing, Kintz Samuel is listed as PRESIDENT AND CEO at Enliven Therapeutics, Inc. Inside the rolling window, Kintz Samuel reported no open-market purchases and 1 open-market sale totaling $273K in ELVN.
Companies traded
Other insiders at ELVN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$273K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 17, 2025 | ELVN | Sale | $267K |
| Sep 26, 2025 | ELVN | Sale | $74K |
| Sep 23, 2025 | ELVN | Sale | $56K |
| Sep 19, 2025 | ELVN | Sale | $20K |
| Sep 17, 2025 | ELVN | Sale | $95K |
Frequently asked questions
How many SEC Form 4 filings has Kintz Samuel made?
Kintz Samuel has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Kintz Samuel trade?
Kintz Samuel has filed SEC Form 4 disclosures for 1 company, including ELVN.
When was Kintz Samuel's most recent SEC Form 4 filing?
Kintz Samuel's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2025.
What is Kintz Samuel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kintz Samuel is listed as PRESIDENT AND CEO.
What is Kintz Samuel's total buy and sell value in the current window?
Inside the rolling retention window, Kintz Samuel bought $0 and sold $273K based on SEC Form 4 filings.
What was Kintz Samuel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,500 ELVN shares on 2025-11-17, worth $273K, per SEC Form 4 filings.